These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21810100)

  • 21. Improvement of an ultrasensitive human immunodeficiency virus type 1 real-time reverse transcriptase-polymerase chain reaction targeting the long terminal repeat region.
    Edelmann A; Kalus U; Oltmann A; Stein A; Unbehaun A; Drosten C; Krüger DH; Hofmann J
    Transfusion; 2010 Mar; 50(3):685-92. PubMed ID: 19906037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.
    Busch MP; Tobler LH; Saldanha J; Caglioti S; Shyamala V; Linnen JM; Gallarda J; Phelps B; Smith RI; Drebot M; Kleinman SH
    Transfusion; 2005 Apr; 45(4):492-9. PubMed ID: 15819668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of HIV infection: role of molecular and immunological assays.
    Weber B
    Expert Rev Mol Diagn; 2006 May; 6(3):399-411. PubMed ID: 16706742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
    Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
    Kretzschmar E; Chudy M; Nübling CM; Ross RS; Kruse F; Trobisch H
    Vox Sang; 2007 May; 92(4):297-301. PubMed ID: 17456153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor.
    Phelps R; Robbins K; Liberti T; Machuca A; Leparc G; Chamberland M; Kalish M; Hewlett I; Folks T; Lee LM; McKenna M
    Transfusion; 2004 Jun; 44(6):929-33. PubMed ID: 15157262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 NAT minipool during the pre-seroconversion window period: detection of a repeat blood donor.
    Palla P; Vatteroni ML; Vacri L; Maggi F; Baicchi U
    Vox Sang; 2006 Jan; 90(1):59-62. PubMed ID: 16359357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
    Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
    Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
    Grabarczyk P; van Drimmelen H; Kopacz A; Gdowska J; Liszewski G; Piotrowski D; Górska J; Kuśmierczyk J; Candotti D; Lętowska M; Lelie N; Brojer E
    Transfusion; 2013 Oct; 53(10 Pt 2):2512-24. PubMed ID: 23590145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suitability of an automated nucleic acid extractor (easyMAG) for use with hepatitis C virus and human immunodeficiency virus type 1 nucleic acid amplification testing.
    Jarvis LM; Mulligan K; Dunsford TH; McGowan K; Petrik J
    J Virol Methods; 2011 Feb; 171(2):364-8. PubMed ID: 21126541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance characteristics of the AmpliScreen HIV-1 test, an assay designed for screening plasma mini-pools.
    Yang Y; Wisbeski MH; Mendoza M; Dorf S; Xu D; Nguyen M; Yeh S; Sun R
    Biologicals; 1999 Dec; 27(4):315-23. PubMed ID: 10686058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
    Bruhn R; Lelie N; Custer B; Busch M; Kleinman S;
    Transfusion; 2013 Oct; 53(10 Pt 2):2399-412. PubMed ID: 23782054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays.
    Foglieni B; Candotti D; Guarnori I; Raffaele L; Berzuini A; Spreafico M; Orani A; Rossotti R; Rossi D; Allain JP; Prati D
    Transfusion; 2011 Apr; 51(4):719-30. PubMed ID: 21087286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of a transcription-mediated-amplification HIV-1 RNA assay in pooled specimens.
    Zetola NM; Mintie A; Liska S; Wong E; Williams JD; Busch MP; Klausner JD
    J Clin Virol; 2007 Sep; 40(1):68-70. PubMed ID: 17662648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.